Miguel Ángel Villasís-Keever, Jessie Nallely Zurita-Cruz, Karla Nava-Sánchez, Aly Sugei Barradas-Vázquez, Ana Laura López-Beltrán, Mireya Elizabeth Espíritu-Díaz, Martha Alicia Delgadillo-Ruano
{"title":"[肥胖症和代谢综合征青少年血清尿酸和肝酶水平的比较]。","authors":"Miguel Ángel Villasís-Keever, Jessie Nallely Zurita-Cruz, Karla Nava-Sánchez, Aly Sugei Barradas-Vázquez, Ana Laura López-Beltrán, Mireya Elizabeth Espíritu-Díaz, Martha Alicia Delgadillo-Ruano","doi":"10.20960/nh.05137","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Introduction: a relationship has been observed between elevated levels of liver enzymes and uric acid with the presence of metabolic syndrome (MS) in the pediatric population. Objective: to compare serum liver enzyme and uric acid levels between adolescents with and without MS. Methods: a cross-sectional study was carried out in adolescents with obesity between 10 and 18 years old. Somatometric data, serum insulin, lipid profile, uric acid levels and liver enzymes (aspartate aminotransferase [AST], alanine aminotransferase [ALT] and gamma-glutamyl transferase [GGT]) were analyzed. Statistical analysis: Student's t test or the Chi-square test was used to evaluate differences between groups. Results: a total of 1095 adolescents with obesity were included (444 with MS and 651 without MS). The group with MS had a higher BMI (with MS 2.28 vs without MS 2.11 p < 0.001), with no difference in body fat (42.9 % vs 42.9 %, p = 0.978). The MS group had significantly higher levels of AST (34.4 vs. 29.5, p = 0.013), ALT (42.2 vs. 34.6, p = 0.003), and uric acid (6.17 vs. 5.74, p = 0.002). comparison to the group without MS. The proportion of ALT (40.5 % vs 29.5 %, p = 0.029) and altered uric acid (58.1 % vs. 45.6 %, p = 0.019) was higher in the MS group. Conclusions: serum levels of ALT, AST and uric acid in adolescents with obesity and MS were higher compared to those without MS. Altered ALT was a risk factor for SM.</p>","PeriodicalId":19385,"journal":{"name":"Nutricion hospitalaria","volume":" ","pages":"933-938"},"PeriodicalIF":2.5000,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Comparison of serum uric acid and liver enzyme levels in adolescents with obesity and with metabolic syndrome].\",\"authors\":\"Miguel Ángel Villasís-Keever, Jessie Nallely Zurita-Cruz, Karla Nava-Sánchez, Aly Sugei Barradas-Vázquez, Ana Laura López-Beltrán, Mireya Elizabeth Espíritu-Díaz, Martha Alicia Delgadillo-Ruano\",\"doi\":\"10.20960/nh.05137\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Introduction: a relationship has been observed between elevated levels of liver enzymes and uric acid with the presence of metabolic syndrome (MS) in the pediatric population. Objective: to compare serum liver enzyme and uric acid levels between adolescents with and without MS. Methods: a cross-sectional study was carried out in adolescents with obesity between 10 and 18 years old. Somatometric data, serum insulin, lipid profile, uric acid levels and liver enzymes (aspartate aminotransferase [AST], alanine aminotransferase [ALT] and gamma-glutamyl transferase [GGT]) were analyzed. Statistical analysis: Student's t test or the Chi-square test was used to evaluate differences between groups. Results: a total of 1095 adolescents with obesity were included (444 with MS and 651 without MS). The group with MS had a higher BMI (with MS 2.28 vs without MS 2.11 p < 0.001), with no difference in body fat (42.9 % vs 42.9 %, p = 0.978). The MS group had significantly higher levels of AST (34.4 vs. 29.5, p = 0.013), ALT (42.2 vs. 34.6, p = 0.003), and uric acid (6.17 vs. 5.74, p = 0.002). comparison to the group without MS. The proportion of ALT (40.5 % vs 29.5 %, p = 0.029) and altered uric acid (58.1 % vs. 45.6 %, p = 0.019) was higher in the MS group. Conclusions: serum levels of ALT, AST and uric acid in adolescents with obesity and MS were higher compared to those without MS. Altered ALT was a risk factor for SM.</p>\",\"PeriodicalId\":19385,\"journal\":{\"name\":\"Nutricion hospitalaria\",\"volume\":\" \",\"pages\":\"933-938\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-10-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nutricion hospitalaria\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.20960/nh.05137\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BUSINESS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nutricion hospitalaria","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.20960/nh.05137","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BUSINESS","Score":null,"Total":0}
引用次数: 0
摘要
导言:在儿科人群中,肝酶和尿酸水平的升高与代谢综合征(MS)的存在有一定的关系。目的:比较患有和未患有代谢综合征的青少年的血清肝酶和尿酸水平。对体格测量数据、血清胰岛素、血脂概况、尿酸水平和肝酶(天冬氨酸氨基转移酶[AST]、丙氨酸氨基转移酶[ALT]和γ-谷氨酰转移酶[GGT])进行了分析:结果:共纳入了 1095 名肥胖青少年(444 名患有多发性硬化症,651 名未患有多发性硬化症)。多发性硬化症组的体重指数(BMI)较高(多发性硬化症组为 2.28,非多发性硬化症组为 2.11,P < 0.001),体脂率无差异(42.9%,P = 0.978)。多发性硬化症组的谷草转氨酶(AST)(34.4 vs. 29.5,p = 0.013)、谷丙转氨酶(ALT)(42.2 vs. 34.6,p = 0.003)和尿酸(6.17 vs. 5.74,p = 0.002)水平明显高于无多发性硬化症组。结论:肥胖和多发性硬化症青少年血清中的谷丙转氨酶(ALT)、谷草转氨酶(AST)和尿酸水平高于无多发性硬化症的青少年。ALT的变化是SM的一个危险因素。
[Comparison of serum uric acid and liver enzyme levels in adolescents with obesity and with metabolic syndrome].
Introduction: Introduction: a relationship has been observed between elevated levels of liver enzymes and uric acid with the presence of metabolic syndrome (MS) in the pediatric population. Objective: to compare serum liver enzyme and uric acid levels between adolescents with and without MS. Methods: a cross-sectional study was carried out in adolescents with obesity between 10 and 18 years old. Somatometric data, serum insulin, lipid profile, uric acid levels and liver enzymes (aspartate aminotransferase [AST], alanine aminotransferase [ALT] and gamma-glutamyl transferase [GGT]) were analyzed. Statistical analysis: Student's t test or the Chi-square test was used to evaluate differences between groups. Results: a total of 1095 adolescents with obesity were included (444 with MS and 651 without MS). The group with MS had a higher BMI (with MS 2.28 vs without MS 2.11 p < 0.001), with no difference in body fat (42.9 % vs 42.9 %, p = 0.978). The MS group had significantly higher levels of AST (34.4 vs. 29.5, p = 0.013), ALT (42.2 vs. 34.6, p = 0.003), and uric acid (6.17 vs. 5.74, p = 0.002). comparison to the group without MS. The proportion of ALT (40.5 % vs 29.5 %, p = 0.029) and altered uric acid (58.1 % vs. 45.6 %, p = 0.019) was higher in the MS group. Conclusions: serum levels of ALT, AST and uric acid in adolescents with obesity and MS were higher compared to those without MS. Altered ALT was a risk factor for SM.
期刊介绍:
The journal Nutrición Hospitalaria was born following the SENPE Bulletin (1981-1983) and the SENPE journal (1984-1985). It is the official organ of expression of the Spanish Society of Clinical Nutrition and Metabolism. Throughout its 36 years of existence has been adapting to the rhythms and demands set by the scientific community and the trends of the editorial processes, being its most recent milestone the achievement of Impact Factor (JCR) in 2009. Its content covers the fields of the sciences of nutrition, with special emphasis on nutritional support.